GILD

Gilead Sciences, Inc. News Headlines

$100.99
*  
2.67
2.58%
Get GILD Alerts
*Delayed - data as of Sep. 15, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Geron Set To Explode As FDA Releases Partial Clinical Hold On Imetelstat Myelofibrosis Trial
6/30/2014 10:47:00 AM - Seeking Alpha

Gilead Will Continue Its Rise
6/26/2014 9:48:00 AM - Seeking Alpha

Gilead Sciences: 7 Different Insiders Have Sold Shares This Month
6/26/2014 8:59:00 AM - Seeking Alpha

GILD May Be A Good Short This Week
6/25/2014 12:16:00 PM - Seeking Alpha

Strength Seen in Vertex Pharmaceuticals Incorporated (VRTX) as Stock Shoots 40.41% - Tale of the Tape
6/25/2014 8:44:00 AM - Zacks.com

4 Convincing Reasons Why Gilead Sciences Should Continue Soaring
6/25/2014 8:34:00 AM - Seeking Alpha

Why Investors Should Sell AbbVie And Buy Gilead Sciences
6/24/2014 6:25:00 PM - Seeking Alpha

Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights - Analyst Blog
6/23/2014 4:45:00 PM - Zacks.com

RegeneRx and Lee's Pharmaceutical Dry Eye Drug Progresses - Analyst Blog
6/23/2014 12:10:00 PM - Zacks.com

Cubist Gains FDA Approval for Sivextro - Analyst Blog
6/23/2014 11:50:00 AM - Zacks.com

Novo Nordisk Reveals Positive Data on Victoza 3 mg - Analyst Blog
6/23/2014 11:30:00 AM - Zacks.com

Analyzing The Hepatitis C Market Size: Why It May Have Bullish Implications For Gilead
6/23/2014 11:15:00 AM - Seeking Alpha

Alkermes plc (ALKS) Jumps: Stock Rises 5.7% - Tale of the Tape
6/23/2014 9:21:00 AM - Zacks.com

Strength Seen in Cara Therapeutics Inc. (CARA) as Stock Rallies 19.60% - Tale of the Tape
6/23/2014 8:44:00 AM - Zacks.com

AstraZeneca's Naloxegol Data Published - Analyst Blog
6/20/2014 6:00:00 PM - Zacks.com

Dividend Yield Vs. Dividend Growth Revisited - Does It Matter?
6/20/2014 4:26:00 PM - Seeking Alpha

OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog
6/20/2014 3:50:00 PM - Zacks.com

Merge Healthcare: Updated Research Report - Analyst Blog
6/20/2014 2:55:00 PM - Zacks.com

Illumina: Updated Research Report - Analyst Blog
6/20/2014 2:30:00 PM - Zacks.com

Celgene Rises on Yet Another Stock Split - Analyst Blog
6/20/2014 11:30:00 AM - Zacks.com

Cubist Gets Priority Review from FDA for Antibiotic Candidate - Analyst Blog
6/20/2014 11:00:00 AM - Zacks.com

Speculators On The Next HCV Acquisition Should Not Overlook Technological Platforms
6/20/2014 10:25:00 AM - Seeking Alpha

Cramer's Lightning Round - I Always Come Back To Palo Alto Networks (6/19/14)
6/20/2014 6:35:00 AM - Seeking Alpha

Protalix Drug in Phase IIa Study for Gaucher Disease - Analyst Blog
6/19/2014 6:15:00 PM - Zacks.com

BioLineRx to Commence BL-8040 Study - Analyst Blog
6/19/2014 6:10:00 PM - Zacks.com